Pulmonx Corp (LUNG) income statement
LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3046% below fair value
$2.57−0.17 (-6.20%)
Close on Nov 20, 2026Market cap $110.38MP/E –Yield –
Pulmonx Corp financial ratios
See a number that looks wrong?